Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
Sharon Varghese, Samson Mathews Samuel, Elizabeth Varghese, et al.
Biomolecules (2019) Vol. 9, Iss. 1, pp. 16-16
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Role of STAT3 signaling pathway in breast cancer
Jiahui Ma, Li Qin, Xia Li
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 310
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 172
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2252-2252
Open Access | Times Cited: 154
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 82
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 14
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Mostafa Vaghari‐Tabari, Gordon A. Ferns, Durdi Qujeq, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 8, pp. 5512-5532
Closed Access | Times Cited: 67
Metformin and Breast Cancer: Where Are We Now?
Mónica Cejuela Solís, Begoña Martı́n-Castillo, Javier A. Menéndez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2705-2705
Open Access | Times Cited: 63
Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 6, pp. e1009634-e1009634
Open Access | Times Cited: 60
Metformin and Breast Cancer: Current Findings and Future Perspectives from Preclinical and Clinical Studies
Karen A. Corleto, Jenna L. Strandmo, Erin D. Giles
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 396-396
Open Access | Times Cited: 10
Metformin as an adjuvant in breast cancer treatment
Mohsin H. K. Roshan, Yan K Shing, Nikolai Paul Pace
SAGE Open Medicine (2019) Vol. 7
Open Access | Times Cited: 55
Mechanisms of metformin inhibiting cancer invasion and migration.
Yong Chang Chen, He Li, Jing Wang
PubMed (2020) Vol. 12, Iss. 9, pp. 4885-4901
Closed Access | Times Cited: 51
High glucose: an emerging association between diabetes mellitus and cancer progression
Suangson Supabphol, Wunchana Seubwai, Sopit Wongkham, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 9, pp. 1175-1193
Closed Access | Times Cited: 51
Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics
Santosh K. Maurya, Smriti Chaudhri, Shashank Kumar, et al.
Pharmaceutical Research (2025)
Closed Access
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
Güven Yenmiş, Elif Yaprak Saraç, Nail Beşli, et al.
Acta Histochemica (2021) Vol. 123, Iss. 4, pp. 151709-151709
Closed Access | Times Cited: 34
Metformin: A promising drug for human cancers (Review)
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Vertebrate cell culture as an experimental approach – limitations and solutions
Mohammad Abbas, Fereshteh Moradi, Wenyu Hu, et al.
Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology (2021) Vol. 254, pp. 110570-110570
Closed Access | Times Cited: 29
CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer
Yan Zhao, Yangyang Yu, Xiangmin Li, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials
Jianhong Liu, Ming Zhang, Dan Deng, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 5, pp. 389-407
Closed Access | Times Cited: 9
Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
Vanitha N. Sivalingam, Ayşe Latif, Sarah Kitson, et al.
British Journal of Cancer (2019) Vol. 122, Iss. 1, pp. 62-71
Open Access | Times Cited: 28
Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
Samson Mathews Samuel, Noothan Jyothi Satheesh, Suparna Ghosh, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1737-1737
Open Access | Times Cited: 25
Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2376-2376
Open Access | Times Cited: 12
Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism
Güven Yenmiş, Nail Beşli, Elif Yaprak Saraç, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 51, Iss. 2, pp. 826-834
Open Access | Times Cited: 18
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
Eleonora Vitali, Ilena Boemi, Giulia Tarantola, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2143-2143
Open Access | Times Cited: 17
Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models
Nan Fang Wang, Toni Rose Jue, Jeff Holst, et al.
BJUI Compass (2022) Vol. 4, Iss. 1, pp. 44-58
Open Access | Times Cited: 9
Inhibiting cytomegalovirus replication through targeting the host electron transport chain
Joseph A. Combs, Chandler H. Monk, Mark A. Harrison, et al.
Antiviral Research (2021) Vol. 194, pp. 105159-105159
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top